Search results
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 4 days agoAs of March, the blockbuster autoimmune drug Humira (adalimumab) still held 96% of the market share...
AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
Investor's Business Daily· 6 days ago"Additionally, recent changes to CVS formularies were accounted for in the full-year outlook."...
Coming to a CVS Near You: A Store Brand Monoclonal Antibody
The Wall Street Journal· 7 days agoThese are cheaper versions of biotech drugs made from living cells, which are far more complicated...
Siliq and cost: Reducing long-term drug costs and more
Medical News Today· 2 days agoSiliq (brodalumab) is a brand-name subcutaneous injection prescribed for plaque psoriasis in adults...
CVS cuts annual profit forecast and flags challenges in 2025, shares fall 18%
Reuters via Yahoo Finance· 5 days ago(Reuters) -CVS Health Corp slashed its annual profit forecast on Wednesday and flagged challenges...
Earnings call: Cigna raises full-year earnings guidance amid growth By Investing.com
Investing.com· 3 days agoGrowth was driven by significant increases in their Specialty businesses within Evernorth and the...
CVS stock plunges after earnings numbers one analyst 'did not even believe'
Yahoo Finance· 4 days agoTo that end, market competition for AbbVie’s (ABBV) Humira, which faced at least five new biosimlar...
Cigna Crushes Q1 Estimates: Revenue Soars With Evernorth's Explosive Growth - Cigna Group (NYSE:CI)
Benzinga· 3 days agoCigna beats sales expectations with a 23% Y/Y increase to $57.26 billion, driven by Evernorth Health...
Cigna writes down VillageMD investment amid shrinking value
Healthcare Dive via Yahoo Finance· 4 days agoWalgreens’ decision to slash VillageMD’s clinical footprint has reverberated to the financial...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 4 days agoFinal thoughts Pfizer is staring down some key patent losses later this decade, and its recent spending spree didn't land an all-star medication like ...